- Home
- LUCD vs OKYO Comparison
LUCD vs OKYO Comparison
Compare LUCD & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- OKYO
- Stock Information
- Founded
- LUCD 2018
- OKYO 2007
- Country
- LUCD United States
- OKYO United Kingdom
- Employees
- LUCD N/A
- OKYO N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LUCD Health Care
- OKYO Health Care
- Exchange
- LUCD Nasdaq
- OKYO Nasdaq
- Market Cap
- LUCD 38.4M
- OKYO 35.5M
- IPO Year
- LUCD 2021
- OKYO 2022
- Fundamental
- Price
- LUCD $0.98
- OKYO $1.05
- Analyst Decision
- LUCD Strong Buy
- OKYO Strong Buy
- Analyst Count
- LUCD 4
- OKYO 1
- Target Price
- LUCD $3.69
- OKYO $7.00
- AVG Volume (30 Days)
- LUCD 535.1K
- OKYO 57.3K
- Earning Date
- LUCD 11-13-2024
- OKYO 11-29-2024
- Dividend Yield
- LUCD N/A
- OKYO N/A
- EPS Growth
- LUCD N/A
- OKYO N/A
- EPS
- LUCD N/A
- OKYO N/A
- Revenue
- LUCD $4,189,000.00
- OKYO N/A
- Revenue This Year
- LUCD $88.47
- OKYO N/A
- Revenue Next Year
- LUCD $238.94
- OKYO N/A
- P/E Ratio
- LUCD N/A
- OKYO N/A
- Revenue Growth
- LUCD 179.27
- OKYO N/A
- 52 Week Low
- LUCD $0.63
- OKYO $0.81
- 52 Week High
- LUCD $1.58
- OKYO $2.12
- Technical
- Relative Strength Index (RSI)
- LUCD 54.35
- OKYO 45.99
- Support Level
- LUCD $0.90
- OKYO $1.01
- Resistance Level
- LUCD $1.12
- OKYO $1.10
- Average True Range (ATR)
- LUCD 0.07
- OKYO 0.06
- MACD
- LUCD -0.01
- OKYO -0.01
- Stochastic Oscillator
- LUCD 36.55
- OKYO 25.00
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.